Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms

Documenti analoghi

• Comparison of Efficacies of a Blonanserin Transdermal Patch and Blonanserin Oral Formulation for Psychiatric Symptoms in Patients With Schizophrenia Treated With Laxatives Using a Japanese Claims Database
  di: Ken Inada, et al.
  Pubblicazione: (2025)
• In Response to “Concerns Regarding Masataka et al.'s ‘Revisiting the Gateway Drug Hypothesis for Cannabis’”
  di: Yuji Masataka, et al.
  Pubblicazione: (2026)
• Longitudinal reduction in brain volume in patients with schizophrenia and its association with cognitive function
  di: Ryuichi Yamazaki, et al.
  Pubblicazione: (2024)
• Treatment‐resistant schizophrenia with 22q11.2 deletion and additional genetic defects
  di: Sawako Furukawa, et al.
  Pubblicazione: (2024)
• Case series of patients with early psychosis presenting hypoperfusion in angular gyrus and self‐disturbance: Implication for the sense of agency and schizophrenia
  di: Akane Yoshikawa, et al.
  Pubblicazione: (2024)